A Study to Extend Efficacy and Safety of SHR-1819 Injection in Adult Patients With Moderate to Severe Atopic Dermatitis
Clinical trial NCT06012812 · COMPLETED
Trial details
- NCT number
- NCT06012812
- Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-06
- Primary completion
- 2025-06-05
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.